Clough Capital Partners L P 2seventy Bio, Inc. Transaction History

Clough Capital Partners L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.14 - $11.2 $57,148 - $203,840	-18,200 Reduced 3.44%	510,910 $2 Million
Q2 2023 Aug 14, 2023	BUY	$8.45 - $12.48 $2.37 Million - $3.5 Million	280,500 Added 112.83%	529,110 $5.35 Million
Q1 2023 May 15, 2023	BUY	$9.21 - $14.98 $2.29 Million - $3.72 Million	248,610 New	248,610 $2.54 Million

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $150M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.